Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ultra-long-acting refillable nanofluidic implant confers full protection against SHIV infection in non-human primates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.15.520646Source: DataRank Database

Ultra-long-acting refillable nanofluidic implant confers full protection against SHIV infection in non-human primates is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (13)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Nicola Di Trani ORCID,Simone Capuani ORCID,Jocelyn Nikita Campa‐Carranza ORCID,Bharti Nehete,Suman Sharma

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4313353609

National Institutes of Health

Grant: 5R01GM127558-02

A nanofluidic platform for tunable drug delivery

National Institutes of Health

Grant: 3P30AI161943-04S2

Texas Developmental Center for AIDS Research

National Institutes of Health

Grant: 5R01AI120749-03

A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis

greenLicense: cc-by-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/12/17/2022.12.15.520646.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.12.15.520646

repositoryhttps://doi.org/10.1101/2022.12.15.520646

Fields of Study

HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment03 medical and health sciences0302 clinical medicine

Keywords

MedicineImplantPeripheral blood mononuclear cellHuman immunodeficiency virus (HIV)ImmunologyIn vitroSurgeryBiology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being